Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 DiabetesNew England Journal of MedicineJune 22, 202510.1056/nejmoa2502082Cited by 94SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis